Biomet's $90 Mil. Cash Biolectron Buy Adds SpinalPak Spinal Stimulator
This article was originally published in The Gray Sheet
Executive Summary
Biomet's $90 mil. cash acquisition of privately-held Biolectron will add the SpinalPak non-invasive spinal stimulator to Biomet's existing orthopedic offerings and complement the firm's SpF implantable spinal fusion stimulation product, Biomet says.